KAISER FOUNDATION HEALTH PLAN, INC.

Lobbying client · California · filed 2025 to 2026

Health Plan

$9,020,000 Reported spend

13 Filings counted

1 Outside firm hired

43 Bills named

Spend is reported income plus in-house expenses across 13 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as KAISER FOUNDATION HEALTH PLAN INC.

Who filed for this client 2

KAISER FOUNDATION HEALTH PLAN INC. $8,570,000 In-house, the client's own filings · 7 filings
MEHLMAN CONSULTING, INC. $450,000 Outside firm · 6 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings top 30 of 43

S. 1105
No UPCODE Act

5 filings
H.R. 247
Health Care Affordability Act of 2025

4 filings
H.R. 6248
Healthy Competition for Better Care Act

4 filings
H.R. 9504
Tax Exempt Hospital Transparency Act

4 filings
S. 46
Health Care Affordability Act of 2025

4 filings
H.R. 5429
Medication Affordability and Patent Integrity Act

3 filings
S. 2780
Medication Affordability and Patent Integrity Act

3 filings
H.R. 1
One Big Beautiful Bill Act

3 filings
H.R. 3269
ETHIC Act

3 filings
H.R. 5526
Biosimilar Red Tape Elimination Act

3 filings
H.R. 7148
Consolidated Appropriations Act, 2026

3 filings
S. 1040
Drug Competition Enhancement Act

3 filings
S. 1041
Affordable Prescriptions for Patients Act

3 filings
S. 1095
Stop STALLING Act

3 filings
S. 1096
Preserve Access to Affordable Generics and Biosimilars Act

3 filings
S. 1097
Interagency Patent Coordination and Improvement Act of 2025

3 filings
S. 1414
Expedited Access to Biosimilars Act

3 filings
S. 1546
Patent Eligibility Restoration Act of 2025

3 filings
S. 1553
PREVAIL Act

3 filings
S. 1954
Biosimilar Red Tape Elimination Act

3 filings
S. 2355
Patients Deserve Price Tags Act

3 filings
S. 2620
REMEDY Act

3 filings
S. 3822
Break Up Big Medicine Act

3 filings
S. 4027
Healthy Competition for Better Care Act

3 filings
S. 527
Prescription Pricing for the People Act of 2025

3 filings
H.R. 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025

2 filings
H.R. 3514
Improving Seniors’ Timely Access to Care Act of 2025

2 filings
H.R. 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…

2 filings
H.R. 5582
Patients Deserve Price Tags Act

2 filings
H.R. 6644
21st Century ROAD to Housing Act

2 filings

Reported by year 2 years

2026 $4,290,000 6 filings
2025 $4,730,000 7 filings

Issues lobbied 9

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 7

HOUSE OF REPRESENTATIVES 12
SENATE 12
Centers For Medicare and Medicaid Services (CMS) 11
Health & Human Services, Dept of (HHS) 11
Defense, Dept of (DOD) 2
Executive Office of the President (EOP) 1
White House Office 1

Recent filings 15 total

Q3 report

MEHLMAN CONSULTING, INC.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 20, 2026

View → Q3 report

KAISER FOUNDATION HEALTH PLAN INC.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $500,000 expenses · posted Oct 16, 2026

View → Q2 report

KAISER FOUNDATION HEALTH PLAN INC.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $530,000 expenses · posted Jul 20, 2026

View → Q2 report

MEHLMAN CONSULTING, INC.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Jul 20, 2026

View → Q4 amendment

KAISER FOUNDATION HEALTH PLAN INC.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $730,000 expenses · posted May 22, 2026

View → Q1 report

MEHLMAN CONSULTING, INC.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $90,000 income · posted Apr 20, 2026

View → Q1 report

KAISER FOUNDATION HEALTH PLAN INC.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $2,990,000 expenses · posted Apr 17, 2026

View → Q4 amendment

KAISER FOUNDATION HEALTH PLAN INC. Amended

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $730,000 expenses · posted Feb 26, 2026

View → Q4 report

MEHLMAN CONSULTING, INC.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 income · posted Jan 20, 2026

View → Q4 report

KAISER FOUNDATION HEALTH PLAN INC. Amended

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $690,000 expenses · posted Jan 16, 2026

View → Q3 report

MEHLMAN CONSULTING, INC.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 17, 2025

View → Q3 report

KAISER FOUNDATION HEALTH PLAN INC.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $340,000 expenses · posted Oct 17, 2025

View → Registration

MEHLMAN CONSULTING, INC.

3rd Quarter 2025 (July 1 - Sep 30) · posted Aug 12, 2025

View → Q2 report

KAISER FOUNDATION HEALTH PLAN INC.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $480,000 expenses · posted Jul 18, 2025

View → Q1 report

KAISER FOUNDATION HEALTH PLAN INC.

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $3,000,000 expenses · posted Apr 17, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.